Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of immunostimulatory effect of intramuscular administration of autologous total IgG in humans
KCT0003258Phase 2Recruiting
- Sponsor
- National Research Foundation
- Start
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of autologous immunoglobulin in Neoplasm, sponsored by National Research Foundation. Started Nov 2018; status: recruiting.
02
Drugs
autologous immunoglobulin
03
Conditions
Neoplasm
Beyond the preview
Go deeper on KCT0003258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003258.